Log in to save to my catalogue

Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of A...

Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_506854

Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies

About this item

Full title

Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies

Publisher

Basel, Switzerland: S. Karger AG

Journal title

American journal of nephrology, 2020-05, Vol.51 (5), p.390-394

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Background: Prolonged use of corticosteroids continues to be the mainstay in the management of most proteinuric glomerulopathies, but is limited by extensive side effects. Alternative medications such as adrenocorticotropic hormone (ACTH) have been recently used to treat refractory glomerulopathies and have shown superior outcomes when compared wit...

Alternative Titles

Full title

Relapse of Nephrotic Syndrome after Adrenocorticotropic Hormone-Induced Remission: Implications of Adrenocorticotropic Hormone Antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_karger_primary_506854

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_506854

Other Identifiers

ISSN

0250-8095

E-ISSN

1421-9670

DOI

10.1159/000506854

How to access this item